Evidence map›Paper›PMID 35276898›Full record

ArticleNutrients2022

ApoE4 Is Associated with Lower Body Mass, Particularly Fat Mass, in Older Women with Cognitive Impairment.

Takafumi Ando, Kazuaki Uchida, Taiki Sugimoto, Ai Kimura, Naoki Saji, Shumpei Niida, Takashi Sakurai

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Skeletal muscle proteome differs between youngFrontiers in aging neuroscience · 2024
    Article
  5. Article
  6. The novel estrogen receptor beta agonist EGX358 andFrontiers in aging neuroscience · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Takafumi AndoCenter for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu 474-8511, Aichi, Japan.ORCID 0000-0003-0357-2939
Kazuaki UchidaCenter for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu 474-8511, Aichi, Japan.
Taiki SugimotoCenter for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu 474-8511, Aichi, Japan.
Ai KimuraMedical Genome Center, National Center for Geriatrics and Gerontology, Obu 474-8511, Aichi, Japan.
Naoki SajiCenter for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu 474-8511, Aichi, Japan.ORCID 0000-0003-4228-1122
Shumpei NiidaResearch Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Aichi, Japan.
Takashi SakuraiCenter for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu 474-8511, Aichi, Japan.
National Center for Geriatrics and Gerontology · JPHyogo University of Health Sciences · JP

Funding

Research Funding of Longevity Sciences from the National Center for Geriatrics and Gerontology 20-56, 21-28
6 · The paper itself

Abstract

A lower body mass is associated with the progression of Alzheimer's disease (AD) and the risk of mortality in patients with AD; however, evidence of genetic determinants of decreased body mass in cognitively impaired older adults is limited. We therefore investigated the genetic effect of APOE-ε4 on body composition in older adults with mild cognitive impairment (MCI) and early-to-moderate-stage AD. A total of 1631 outpatients (aged 65-89 years) with MCI and early-to-moderate-stage AD were evaluated for the association between body composition and APOE-ε4 status. After adjusting for covariates, including cognitive function evaluated with the Mini-Mental State Examination, the presence of the APOE-ε4 was associated with lower weight (β = -1.116 ± 0.468 kg per presence,

Indexed as

Alzheimer DiseaseCognition DisordersCognitive DysfunctionAgedAged, 80 and overAge FactorsApolipoprotein E4CognitionFemaleHumansMaleApolipoprotein E4Alzheimer’s diseaseApoEcross-sectional studyfat-free massfat massoutpatient study

Identifiers

PMID35276898
PMCPMC8838979
OpenAlexW4210243305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.